Stanley Druckenmiller’s portfolio: Duquesne Family Office 13F holdings

Quarterly SEC 13F-HR filingsCIK 0001536411Latest: Q2 2026

Q4 2024 filing in brief

In its Q4 2024 13F, filed February 14, 2025, Duquesne Family Office reported $3.7B across 78 US positions. The largest: NTRA (15.2%), COHR (7.2%), WWD (5.5%), TEVA (5.3%), CPNG (5.3%). In the quarter it opened 24 positions, sold out of 21, added to 24 and trimmed 15; positions opened and sold out came to 34% of the portfolio's value.

Methodology

Holdings come from the manager’s Form 13F-HR filings on SEC EDGAR, with amendments applied. Values and shares are reported at quarter-end; the filing date is when the report became public. These disclosures show reported long positions and listed options, not the manager’s entire portfolio or its trades since quarter-end.

Quarterly changes compare shares with the immediately preceding quarter on file. New and exited positions appear or disappear; added and trimmed positions change their share count by more than 1%. A share change can also reflect a stock split or other corporate action.

Opened and sold out is the value of new positions plus the prior value of exited positions, divided by the average of the two quarters’ reported portfolio values. It excludes changes to positions still held. Reported value growth includes price changes and is not a measure of investment performance. Largest-five and largest-ten weights exclude options.

Holdings

Filed Feb 14, 2025

  • 24 New
  • 24 Added
  • 15 Trimmed
  • 21 Exited

78 positions at December 31, 2024. Q/Q change compares shares with the preceding quarter.

RowTickerIssuerStatus
1NTRANatera Inc$565M3.6M15.17%0.0%Held
2COHRCoherent Corp$267M2.8M7.18%−5.3%Trimmed
3WWDWoodward Inc$204M1.2M5.48%+15.9%Added
4TEVATeva Pharmaceutical Inds Ltd$198M9.0M5.33%+530.1%Added
5CPNGCoupang Inc$196M8.9M5.26%−23.9%Trimmed
6PMPhilip Morris Intl Inc$163M1.4M4.37%+19.2%Added
7—Seagate Technology Hldngs Pl$135M1.6M3.63%−4.7%Trimmed
8UALUnited Airls Hldgs Inc$101M1.0M2.72%—New
9MELIMercadolibre Inc$91M53.7K2.45%+11.7%Added
10SKAASkechers U S A Inc$72M1.1M1.94%—New
11AMZNAmazon Com Inc$72M328.4K1.94%—New
12YPFYpf Sociedad Anonima$72M1.7M1.93%+292.4%Added
13SLMSlm Corp$70M2.5M1.87%—New
14KMIKinder Morgan Inc Del$61M2.2M1.64%−14.8%Trimmed
15DALDelta Air Lines Inc Delcall option$57M949.5K1.54%—New
16USX1United States Stl Corp$55M1.6M1.47%+142.8%Added
17WABWabtec$53M280.1K1.43%+55.9%Added
18DALDelta Air Lines Inc Del$49M817.7K1.33%—New
19WBDWarner Bros Discovery Inc$49M4.7M1.32%—New
20LLYEli Lilly & Co$48M62.2K1.29%—New
21BMABanco Macro Sa$47M485.4K1.26%+14.5%Added
22ARGTGlobal X Fds$45M548.8K1.22%+94.6%Added
23AALAmerican Airlcall option$45M2.6M1.20%—New
24DAKTDaktronics Inc$44M2.6M1.19%+2.2%Added
25—Seagate Technology Hldngs Plcall option$44M509.5K1.18%+93.7%Added
26BCSBarclays Plc$42M3.2M1.14%+58.7%Added
27VRNAVerona Pharma Plc$41M887.6K1.11%+29.4%Added
28INSMInsmed Inc$41M593.5K1.10%+2867.3%Added
29VSTVistra Corp$39M283.4K1.05%−27.6%Trimmed
30ASNDAscendis Pharma A/S$36M265.0K0.98%0.0%Held
31BNBrookfield Corp$35M610.2K0.94%—New
32MUMicron Technology Inc$34M408.9K0.92%—New
33KRESpdr Ser Tr$33M554.1K0.90%−73.0%Trimmed
34BWXTBwx Technologies Inc$33M299.2K0.90%—New
35GEVGe Vernova Inc$33M99.8K0.88%+241.0%Added
36—Springworks Therapeutics Inc$31M859.7K0.83%+21.9%Added
37—Nvent Electric Plc$31M451.1K0.83%0.0%Held
38FCXFreeport-Mcmoran Inc$29M758.9K0.78%−44.9%Trimmed
39GGALGrupo Financiero Galicia S.A$28M448.7K0.75%+26.3%Added
40DFSEURDiscover Finl Svcs$25M147.0K0.68%−48.4%Trimmed
41WDCWestern Digital Corp$25M417.2K0.67%+484.2%Added
42USBUs Bancorp Del$24M503.6K0.65%+131.6%Added
43ARMArm Holdings Plc$22M178.4K0.59%+725.5%Added
44UALUnited Airls Hldgs Inccall option$22M226.0K0.59%—New
45TSMTaiwan Semiconductor Mfg Ltd$21M107.5K0.57%+87.5%Added
46GTMZoominfo Technologies Inc$19M1.8M0.50%−17.7%Trimmed
47TECKTeck Resources Ltd$17M431.5K0.47%−57.6%Trimmed
48PCTPurecycle Technologies Inc$16M1.6M0.44%—New
49AALAmerican Airl$16M919.9K0.43%—New
50PANWPalo Alto Networks Inc$16M87.4K0.43%+100.0%Added
51TSLATesla Inc$15M37.7K0.41%—New
52GOOGLAlphabet Inc$15M76.7K0.39%—New
53—Flex Ltd$13M348.9K0.36%0.0%Held
54FHNFirst Horizon Corporation$12M619.7K0.34%0.0%Held
55WFCWells Fargo Co New$11M157.1K0.30%—New
56FCNCAFirst Ctzns Bancshares Inc N$11M5.2K0.29%0.0%Held
57HBANHuntington Bancshares Inc$11M671.2K0.29%0.0%Held
58LYVLive Nation Entertainment In$10M79.6K0.28%—New
59TFCTruist Finl Corp$10M233.5K0.27%0.0%Held
60ABCBAmeris Bancorp$10M154.0K0.26%0.0%Held
61KEYKeycorp$9M527.0K0.24%−9.7%Trimmed
62WULFTerawulf Inc$8M1.5M0.22%−50.0%Trimmed
63—Newamsterdam Pharma Company$7M287.5K0.20%0.0%Held
64PCVXVaxcyte Inc$7M86.3K0.19%+100.8%Added
65CRNXCrinetics Pharmaceuticals In$6M122.7K0.17%−60.3%Trimmed
66MIRMirion Technologies Inc$6M342.7K0.16%—New
67SNRENSunrise Communications Ag Ads$6M133.2K0.15%—New
68ACLXGBXArcellx Inc$6M74.1K0.15%0.0%Held
69CCitigroup Inc$5M72.7K0.14%−77.8%Trimmed
70NUNu Hldgs Ltd$5M467.3K0.13%—New
71ELFE L F Beauty Inc$5M37.3K0.13%—New
72FLUTFlutter Entmt Plc$5M18.1K0.13%−93.1%Trimmed
73IQVIqvia Hldgs Inc$4M21.5K0.11%—New
74RAREUltragenyx Pharmaceutical In$4M85.4K0.10%0.0%Held
75PLTRPalantir Technologies Inc$3M41.7K0.08%0.0%Held
76TLSITrisalus Life Sciences Inc$2M426.9K0.06%0.0%Held
77—Joby Aviation Inc$256K31.5K0.01%+40.0%Added
78IVVDInvivyd Inc$253K571.4K0.01%0.0%Held
21 exited positions

Positions held in the preceding quarter and absent from this filing. Values and shares are from the preceding quarter.

TickerIssuerPrevious valuePrevious shares
PMPhilip Morris Intl Inccall option$57M472.2K
AVGOBroadcom Inc$41M240.0K
MAAMid-Amer Apt Cmntys Inc$38M238.7K
CPTCamden Ppty Tr$36M290.9K
CNMCore & Main Inc$21M475.2K
MSFTMicrosoft Corp$19M43.1K
ADBEAdobe Inc$18M34.5K
—Crh Plc$15M162.5K
TPGTpg Incput option$13M217.5K
CBChubb Limited$10M34.8K
ADSKAutodesk Inc$10M36.4K
MTBM & T Bk Corp$10M56.2K
CFGCitizens Finl Group Inc$10M238.6K
SPRYArs Pharmaceuticals Inc$8M536.9K
SLNSilence Therapeutics Plc$7M387.4K
TRPTc Energy Corp$5M115.4K
SBUXStarbucks Corp$5M52.3K
XPOXpo Inc$5M46.5K
BCYCBicycle Therapeutics Plc$4M190.2K
—Ihs Holding Limited$2M770.3K
NRIXNurix Therapeutics Inc$993K44.2K
Every quarter on file (53)

From the manager’s Form 13F-HR filings on SEC EDGAR, amendments applied. Long US positions only; not a recommendation.